pregabalin medical valley hart hylki 150 mg
medical valley invest ab - pregabalinum inn - hart hylki - 150 mg
brieka hart hylki 300 mg
teva b.v.* - pregabalinum inn - hart hylki - 300 mg
brieka hart hylki 25 mg
teva b.v.* - pregabalinum inn - hart hylki - 25 mg
pregabalin krka hart hylki 100 mg
krka, d.d., novo mesto - pregabalinum inn - hart hylki - 100 mg
pregabalin krka hart hylki 150 mg
krka, d.d., novo mesto - pregabalinum inn - hart hylki - 150 mg
pregabalin krka hart hylki 25 mg
krka, d.d., novo mesto - pregabalinum inn - hart hylki - 25 mg
pregabalin krka hart hylki 50 mg
krka, d.d., novo mesto - pregabalinum inn - hart hylki - 50 mg
pregabalin krka hart hylki 75 mg
krka, d.d., novo mesto - pregabalinum inn - hart hylki - 75 mg
pregabalin medical valley hart hylki 300 mg
medical valley invest ab - pregabalinum inn - hart hylki - 300 mg
vipdomet
takeda pharma a/s - rannsóknir á dýra, kvarta stutt og long-term - sykursýki, tegund 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - vipdomet is indicated in the treatment of adult patients aged 18 years and older with type-2 diabetes mellitus:as an adjunct to diet and exercise to improve glycaemic control in adult patients, inadequately controlled on their maximal tolerated dose of metformin alone, or those already being treated with the combination of alogliptin and metformin;in combination with pioglitazone (i. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled on their maximal tolerated dose of metformin and pioglitazone;in combination with insulin (i. þrefaldur samsetning meðferð) sem viðbót til að fæði og æfa til að bæta blóðsykursstjórnun í sjúklinga þegar insúlín í stöðugu skammtur og kvarta einn veita ekki fullnægjandi blóðsykursstjórnun.